The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava.
about
Clinical Practice Guideline: TinnitusGinkgo biloba for tinnitusGinkgo biloba for tinnitusEffects of pumpkin seed oil and saw palmetto oil in Korean men with symptomatic benign prostatic hyperplasiaThe use of gene expression analysis and proteomic databases in the development of a screening system to determine the value of natural medicinal products.Pharmacotherapy for anxiety disorders in children and adolescentsA Systematic Review and Meta-Analysis of Ginkgo biloba in Neuropsychiatric Disorders: From Ancient Tradition to Modern-Day MedicineGenomics and proteomics of immune modulatory effects of a butanol fraction of echinacea purpurea in human dendritic cells.American Ginseng Extract (Panax quinquefolius L.) Is Safe in Long-Term Use in Type 2 Diabetic Patients.An analysis of Echinacea chloroplast genomes: Implications for future botanical identification.Stimulatory effect of Echinacea purpurea extract on the trafficking activity of mouse dendritic cells: revealed by genomic and proteomic analyses.Risks of combined alcohol/medication use in older adults.Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial.Efficacy of a standardized echinacea preparation (Echinilin) for the treatment of the common cold: a randomized, double-blind, placebo-controlled trial.Buyer beware? Does the information provided with herbal products available over the counter enable safe use?Pharmacokinetic interaction between losartan and Rhodiola rosea in rabbits.Barriers to planning and conducting a screening: prostate cancer.Adulteration and cultivation region identification of American ginseng using HPLC coupled with multivariate analysisDeveloping optimal search strategies for detecting clinically sound treatment studies in EMBASEInhibition of human cytochromes P450 by components of Ginkgo biloba.Functional foods, herbs and nutraceuticals: towards biochemical mechanisms of healthy aging.Non-interventional management of resistant hypertension.The potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription products.Utility of nutraceutical products marketed for cognitive and memory enhancementPotential medicinal plants for CNS disorders: an overview.Herbal medicines for the treatment of rhinosinusitis: a systematic review.Multifaceted therapeutic benefits of Ginkgo biloba L.: chemistry, efficacy, safety, and uses.Complementary and alternative medicine use among US adults with common neurological conditions.Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk.Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature: a case report and systematic review of the literature.Use of mind-body medical therapies.Patient-centered communication: do patients really prefer it?Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy -- case report and review of literature.Interactions of herbs with cytochrome P450.Is the increasing use of evidence-based pharmacotherapy causing the renaissance of complementary medicine?Evaluation and management of the elderly patient presenting with cognitive complaints.Central nervous system toxicity from cancer treatment.Dermatologic manifestations of complementary therapy.Evaluation of potential drug- herb interactions among a group of Palestinian patients with chronic diseasesChloroform Fraction of Centratherum anthelminticum (L.) Seed Inhibits Tumor Necrosis Factor Alpha and Exhibits Pleotropic Bioactivities: Inhibitory Role in Human Tumor Cells.
P2860
Q22241833-1D6D050F-33F3-4F3A-BE87-028F759DC1A1Q24200193-BCB55166-6A54-4410-8299-D634D4ACCAEEQ24247153-FB8672C6-8113-440E-979A-F3D1F2390918Q24642371-4230EE7B-7CCA-43F3-A48B-56B919A5EDF7Q25257585-C4D650C8-6EF3-4879-93A2-07038737FF9DQ26853715-C687891C-31C3-42BC-9F36-DCDE1243EA87Q28681531-A052602C-D988-467D-8524-44D5A0A01BFFQ33375228-744C1C24-399D-4E8D-9288-EE1BAE89E9E7Q33661345-4CA494A1-BF44-4414-94E7-DDE708A91C5CQ33671183-EE052CE7-7F5D-49CE-AECB-C6DB613CD997Q33735322-DE714C9E-9312-4490-9EE3-6355ED306D8DQ33776601-D49A010B-4524-471A-97E8-82D599C850CEQ33846696-1A672142-952E-4560-954A-913836BFBBA8Q33975378-15FD03AA-0FBD-4833-A9FC-A4C8E1B88CB0Q33986613-B55F7364-EA55-4648-AE6B-3020AF9F18E0Q34035121-6F3F95B7-27A3-43AD-919D-AF5AEF504D71Q34041005-EFA5FA51-1B58-4F82-ACDA-688478D89D65Q34117936-323C5607-DA18-4A75-8F03-79DD4CAAD10CQ34247488-CC7B1ACD-81B9-4535-814C-32F3CBC28EE7Q34337497-B0A791B1-0D90-4935-B474-3ECCABA5406DQ34368481-9536BEFC-B216-4A64-AAD2-799928B87549Q34404475-462BF835-3E4D-414D-9597-A552CC911F7AQ34432298-6B9FEA0B-E566-4376-A7D1-67E519FB32A9Q34463098-5718A78B-7BBE-4F39-9006-FDFC5DC6417BQ34557415-31C60E57-EE1F-46E7-AB43-354AD688CE0FQ34570187-9F5B9F42-B67D-46A0-B700-4CAF5EF20193Q34587422-EB786686-80BA-49C3-8C64-98EACDE6D2A7Q34632333-D57FF228-5101-4968-BE5C-24C78CC29EC9Q34647657-7D6E95E2-37CD-4C46-9458-5048398E6AA8Q34723619-44EB0520-24C3-4B13-A4F5-0965932A808CQ34740173-F3DAB9BF-E5AA-4D83-B488-355D9798B789Q34740711-CE9FBF3E-074B-4576-A3FA-FAB4A95EAB04Q35025489-9D8FF011-4DCC-4C15-B59B-6B398551527EQ35085032-F5536B53-8397-43F7-8307-5E29D752DD86Q35200060-8C1E25F1-CD1C-4F40-95BC-5CA904D214F4Q35447239-173DCA9E-7479-4911-A6FF-7AC8E871F77BQ35603867-B20D95FB-588D-4BCB-AE9C-15DD56BD07D8Q35606937-F1C03D3C-EEF9-4CAE-B5DD-90674826812AQ35688442-FFF8A0C3-D948-45AD-AACD-1A538218F935Q35830073-D2809C12-A5AC-446C-BD55-6CA7EC8C5A6D
P2860
The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The risk-benefit profile of co ...... nacea, Saw Palmetto, and Kava.
@ast
The risk-benefit profile of co ...... nacea, Saw Palmetto, and Kava.
@en
The risk-benefit profile of co ...... nacea, Saw Palmetto, and Kava.
@nl
type
label
The risk-benefit profile of co ...... nacea, Saw Palmetto, and Kava.
@ast
The risk-benefit profile of co ...... nacea, Saw Palmetto, and Kava.
@en
The risk-benefit profile of co ...... nacea, Saw Palmetto, and Kava.
@nl
prefLabel
The risk-benefit profile of co ...... nacea, Saw Palmetto, and Kava.
@ast
The risk-benefit profile of co ...... nacea, Saw Palmetto, and Kava.
@en
The risk-benefit profile of co ...... nacea, Saw Palmetto, and Kava.
@nl
P1476
The risk-benefit profile of co ...... nacea, Saw Palmetto, and Kava.
@en
P356
10.7326/0003-4819-136-1-200201010-00010
P407
P50
P577
2002-01-01T00:00:00Z